Fluticasone propionate
Side effects
Options:
Show MedDRA Preferred Terms
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
Candida infection
|
very common, 3% - 13.7%
|
8.3%
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Lower respiratory tract infection
|
6.9% - 8.7%
|
9.4%
|
|
|
|
|
|
x
|
|
|
|
|
|
|
|
Oral candidiasis
|
very common, 1% - 7%
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Dysphonia
|
1.5% - 7%
|
|
|
|
x
|
|
x
|
|
|
|
|
|
|
|
|
Upper respiratory tract infection
|
1% - 16.5%
|
13.5%
|
|
|
x
|
|
|
x
|
|
|
|
|
|
|
|
Asthma
|
1% - 34.3%
|
2.9% - 41.7%
|
|
|
x
|
|
|
x
|
|
|
x
|
|
|
|
|
Contusion
|
common
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Hoarseness
|
postmarketing — 1.5% - 7%
|
1%
|
|
|
x
|
x
|
x
|
x
|
|
|
x
|
x
|
x
|
x
|
x
|
Dry throat
|
common
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
|
Nausea
|
2.6% - 5%
|
2%
|
|
|
|
|
|
x
|
x
|
|
x
|
x
|
x
|
x
|
x
|
Vomiting
|
2.6% - 5%
|
2%
|
|
|
|
|
|
x
|
x
|
|
x
|
x
|
x
|
x
|
x
|
Cough
|
postmarketing, 3.6% - 9.8%
|
2.8% - 6.3%
|
|
|
x
|
|
|
x
|
|
|
x
|
x
|
x
|
x
|
x
|
Bronchitis
|
2% - 4.9%
|
5.2%
|
|
|
|
|
|
x
|
|
|
x
|
|
|
|
|
Nasal irritation
|
common, 2.4% - 3.2%
|
2.6%
|
|
|
|
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Nasal dryness
|
common, 1.3%
|
|
|
|
|
|
|
|
x
|
x
|
|
x
|
x
|
x
|
x
|
Epistaxis
|
very common, 1.6% - 13.3%
|
2.2% - 5.4%
|
|
|
|
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Malaise
|
1% - 4.9%
|
2.1%
|
|
|
|
|
|
x
|
|
|
|
|
|
x
|
x
|
Nasal soreness
|
2.5%
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Nasal burning
|
1% - 3.4%
|
1.2% - 2.6%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Excoriation
|
2%
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Rash erythematous
|
2%
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Throat sore
|
postmarketing, 1% - 4%
|
|
|
|
x
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Sinusitis
|
1.6%
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Headache
|
postmarketing — 1.2% - 16.1%
|
1.2% - 14.6%
|
|
|
x
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Pharyngitis
|
0% - 7.8%
|
0% - 7.2%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Pruritus
|
postmarketing, 0.493% - 5.13%
|
|
x
|
x
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Urticaria
|
postmarketing, 2%
|
|
x
|
x
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Throat irritation
|
postmarketing — 1%
|
|
|
|
x
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Skin irritation
|
0% - 2.86%
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Stinging
|
0% - 1.28%
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Cutaneous hypersensitivity
|
uncommon
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Sneezing
|
0% - 1.2%
|
0% - 2.2%
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Abdominal discomfort
|
1%
|
|
|
|
|
|
|
x
|
|
|
|
|
|
|
|
Nasal ulcer
|
postmarketing, 0% - 1.2%
|
0% - 1.2%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Rhinorrhoea
|
1% - 1.6%
|
1%
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Erythema
|
0% - 2%
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Eczema
|
0% - 1.9%
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Folliculitis
|
0% - 0.493%
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Eczema infected
|
0% - 0.985%
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Sinus headache
|
0.3%
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Rash
|
very rare — 0.2% - 1%
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Nasal septum perforation
|
very rare — 0.1%
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Angioedema
|
very rare — rare
|
|
|
|
x
|
x
|
x
|
x
|
|
|
x
|
x
|
x
|
x
|
x
|
Conjunctivitis
|
postmarketing
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Dyspnoea
|
very rare — rare
|
|
|
|
x
|
x
|
x
|
x
|
|
|
x
|
x
|
x
|
x
|
x
|
Wheezing
|
postmarketing
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Eye irritation
|
postmarketing
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Anaphylactoid reaction
|
postmarketing
|
|
|
|
|
|
|
|
x
|
|
x
|
|
x
|
x
|
x
|
Vision blurred
|
postmarketing
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Face oedema
|
postmarketing
|
|
|
|
|
|
|
|
|
|
x
|
|
x
|
x
|
x
|
Bronchospasm
|
very rare — rare
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Glaucoma
|
very rare — rare
|
|
|
|
|
x
|
x
|
x
|
|
x
|
|
|
x
|
|
|
Hypersensitivity
|
very rare, postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Cataract
|
very rare — rare
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Growth retardation
|
very rare, rare
|
|
|
|
x
|
x
|
x
|
x
|
|
|
x
|
|
|
|
|
Intraocular pressure increased
|
very rare, postmarketing
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Bronchospasm paradoxical
|
very rare, rare
|
|
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Secondary adrenocortical insufficiency
|
very rare, rare
|
|
|
x
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Oropharyngeal swelling
|
very rare, rare
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Anaphylactic shock
|
very rare, postmarketing
|
|
|
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
x
|
Anxiety
|
very rare
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Mental disorder
|
very rare
|
|
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Cushing's syndrome
|
very rare
|
|
|
|
x
|
x
|
x
|
x
|
|
|
x
|
|
|
|
|
Oedema
|
very rare
|
|
|
|
|
|
|
|
x
|
x
|
|
x
|
|
|
|
Hyperglycaemia
|
very rare
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Irritability
|
very rare
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Hyperkinesia
|
very rare
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Sleep disorder
|
very rare
|
|
|
|
x
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Abdominal distension
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
|
|
Abdominal pain
|
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
Hyperadrenocorticism
|
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
Blister
|
0% - 0.493%
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Chest pain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
Infection
|
|
|
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Dermatitis atopic
|
0% - 0.476%
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Diabetes mellitus
|
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
Diarrhoea
|
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
Dizziness
|
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
Endocrine disorder
|
|
|
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Eye disorder
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
|
Body temperature increased
|
|
|
|
|
x
|
|
|
|
|
|
x
|
|
|
|
|
Fracture
|
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
Herpes simplex
|
0% - 0.493%
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Hypertension
|
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
Hypertrichosis
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
Immune system disorder
|
|
|
|
|
|
x
|
x
|
x
|
|
x
|
|
|
|
|
|
Impetigo
|
0% - 0.476%
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Mediastinal disorder
|
|
|
|
|
|
x
|
x
|
x
|
|
x
|
|
|
|
|
|
Menopause
|
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
Miliaria
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Nasal congestion
|
0% - 1.2%
|
0%
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Nervous system disorder
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
|
Osteopenia
|
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
Osteoporosis
|
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
Pain
|
|
|
|
|
|
|
|
|
|
|
x
|
|
|
x
|
x
|
Perennial allergic rhinitis
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
x
|
Skin infection
|
0% - 0.476%
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Telangiectasia
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Viral infection
|
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
Common wart
|
0% - 0.493%
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Dry mouth
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Skin atrophy
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Hypogeusia
|
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
Pustular psoriasis
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Skin striae
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Malnutrition
|
|
|
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Allergic contact dermatitis
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Leukoderma
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Acneiform eruption
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Unspecified disorder of skin and subcutaneous tissue
|
|
|
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Scab
|
0% - 1.2%
|
0%
|
|
|
|
|
|
|
x
|
|
|
x
|
x
|
x
|
x
|
Lightheadedness
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
|
Ache
|
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
Dermatitis perioral
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Influenza-like symptoms
|
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
Plaque psoriasis
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Lacrimation
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Secondary infection
|
|
|
x
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Sinus pain
|
|
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
Swelling of eyelid
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
Numbness in fingers
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Infestation NOS
|
|
|
|
|
|
x
|
x
|
x
|
|
|
|
|
|
|
|
Telangiectasis facial
|
|
|
|
x
|
|
|
|
|
|
|
|
|
|
|
|
Stinging of nose
|
|
|
|
|
|
|
|
|
|
|
|
x
|
x
|
x
|
x
|
Ageusia
|
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
|
Rhinitis allergic
|
|
|
|
|
|
|
|
|
|
|
|
x
|
|
|
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 16 |
Source: | FDA |
---|
Side effects: | 29 |
Source: | FDA |
---|
Side effects: | 34 |
Source: | Health Canada |
---|
Side effects: | 30 |
Source: | Medsafe |
---|
Side effects: | 35 |
Source: | medicines.org.au |
---|
Side effects: | 42 |
Source: | medicines.org.au |
---|
Side effects: | 18 |
Source: | medicines.org.au |
---|
Side effects: | 19 |
Source: | Medsafe |
---|
Side effects: | 44 |
Source: | FDA |
---|
Side effects: | 43 |
Source: | medicines.org.au |
---|
Side effects: | 43 |
Source: | Health Canada |
---|
Side effects: | 46 |
Source: | Health Canada |
---|
Side effects: | 46 |
Source: | Health Canada |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|